Trevi Therapeutics Inc (TRVI)

Trevi Therapeutics Inc (TRVI) 財務データ

損益計算書

四半期ごと

*すべての数値は百万単位です

期間終了日	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31
期間の長さ	3 か月	3 か月	3 か月	3 か月	3 か月
Revenues	-	-	-	-	-
Operating Expenses	33.28% 11.91	8.933	9.045	8.382	7.563
Interest Income/Expense	75.00% 0.001	0.004	0.003	0.153	0.231
Operating Income/Loss	33.28% -11.91	-8.933	-9.045	-8.382	-7.563
Nonoperating Income/Loss	11.86% 0.996	1.13	1.334	1.207	1.155
Income/Loss From Continuing Operations Before Tax	39.82% -10.91	-7.803	-7.711	-7.175	-6.408
Income Tax Expense/Benefit	144.44% -0.008	0.018	-0.013	-0.03	-0.007
Income/Loss From Continuing Operations After Tax	39.39% -10.90	-7.821	-7.698	-7.145	-6.401
Net Income/Loss	39.39% -10.90	-7.821	-7.698	-7.145	-6.401
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	65,161% 99.52	0.1525	99.33	98.70	98.61
Diluted Average Shares	65,161% 99.52	0.1525	99.33	98.70	98.61
Basic Earnings Per Share	37.50% -0.11	-0.08	-0.08	-0.07	-0.06
Diluted Earnings Per Share	37.50% -0.11	-0.08	-0.08	-0.07	-0.06
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-